Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm A Martin

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Journal of Virology|September 30, 2016
Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 IsolatesChia-Yen Chen, Masashi Shingai, Sarah Welbourn, et al.
Journal of Virology|February 12, 2002
Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodiesYoshiaki Nishimura, Tatsuhiko Igarashi, Nancy Haigwood, et al.
Journal of Virology|March 23, 2007
Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDSCharles R Brown, Meggan Czapiga, Juraj Kabat, et al.
Journal of Virology|April 29, 2004
Induction of disease by a molecularly cloned highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimera is multigenicReza Sadjadpour, Theodore S Theodore, Tatsuhiko Igarashi, et al.
Journal of Virology|May 31, 2013
Emergence of gp120 V3 variants confers neutralization resistance in an R5 simian-human immunodeficiency virus-infected macaque elite neutralizer that targets the N332 glycan of the human immunodeficiency virus type 1 envelope glycoproteinReza Sadjadpour, Olivia K Donau, Masashi Shingai, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2006
Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cellsKazuya Kamada, Tatsuhiko Igarashi, Malcolm A Martin, et al.
Journal of Virology|May 8, 2009
Initiation of antiretroviral therapy 48 hours after infection with simian immunodeficiency virus potently suppresses acute-phase viremia and blocks the massive loss of memory CD4+ T cells but fails to prevent diseaseMakoto Kubo, Yoshiaki Nishimura, Masashi Shingai, et al.
Journal of Visualized Experiments : Jove|February 27, 2023
Gene Editing of Primary Rhesus Macaque B CellsHarald Hartweger, Rajeev Gautam, Yoshiaki Nishimura, et al.
Journal of Virology|November 12, 2005
CD8+ and CD20+ lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotypeHanwen Mao, Bernard A P Lafont, Tatsuhiko Igarashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2009
High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infectionsYoshiaki Nishimura, Reza Sadjadpour, Joseph J Mattapallil, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Journal of Virology|September 30, 2016
Antagonism of BST-2/Tetherin Is a Conserved Function of the Env Glycoprotein of Primary HIV-2 IsolatesChia-Yen Chen, Masashi Shingai, Sarah Welbourn, et al.
Journal of Virology|February 12, 2002
Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodiesYoshiaki Nishimura, Tatsuhiko Igarashi, Nancy Haigwood, et al.
Journal of Virology|March 23, 2007
Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDSCharles R Brown, Meggan Czapiga, Juraj Kabat, et al.
Journal of Virology|April 29, 2004
Induction of disease by a molecularly cloned highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimera is multigenicReza Sadjadpour, Theodore S Theodore, Tatsuhiko Igarashi, et al.
Journal of Virology|May 31, 2013
Emergence of gp120 V3 variants confers neutralization resistance in an R5 simian-human immunodeficiency virus-infected macaque elite neutralizer that targets the N332 glycan of the human immunodeficiency virus type 1 envelope glycoproteinReza Sadjadpour, Olivia K Donau, Masashi Shingai, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2006
Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cellsKazuya Kamada, Tatsuhiko Igarashi, Malcolm A Martin, et al.
Journal of Virology|May 8, 2009
Initiation of antiretroviral therapy 48 hours after infection with simian immunodeficiency virus potently suppresses acute-phase viremia and blocks the massive loss of memory CD4+ T cells but fails to prevent diseaseMakoto Kubo, Yoshiaki Nishimura, Masashi Shingai, et al.
Journal of Visualized Experiments : Jove|February 27, 2023
Gene Editing of Primary Rhesus Macaque B CellsHarald Hartweger, Rajeev Gautam, Yoshiaki Nishimura, et al.
Journal of Virology|November 12, 2005
CD8+ and CD20+ lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotypeHanwen Mao, Bernard A P Lafont, Tatsuhiko Igarashi, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2009
High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infectionsYoshiaki Nishimura, Reza Sadjadpour, Joseph J Mattapallil, et al.
Pageof 7